Cargando…
Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model
Liquid biopsy is a noninvasive technique that can provide valuable information for disease characterization by using biofluids as a source of biomarkers. Proteins found in biofluids can offer a wealth of information for understanding pathological processes. In this study, we used early-stage clear c...
Autores principales: | liu, Xiaoyan, Zhang, Mingxin, Shao, Chen, Sun, Haidan, Zhang, Binbin, Guo, Zhengguang, Sun, Jiameng, Qi, Feng, Zhang, Yushi, Niu, Haitao, Sun, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416070/ https://www.ncbi.nlm.nih.gov/pubmed/37348606 http://dx.doi.org/10.1016/j.mcpro.2023.100603 |
Ejemplares similares
-
Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019) -
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2019) -
LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
por: Liu, Xiang, et al.
Publicado: (2020) -
Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018) -
Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma Biomarker
por: Liu, Xiaoyan, et al.
Publicado: (2020)